Eupraxia Pharmaceuticals Inc. (EPRX.TO)
CAD 4.59
(-2.34%)
CAD 4.59
(-2.34%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 37.92 Million CAD | 63.44% |
| 2022 | 23.2 Million CAD | 24.23% |
| 2021 | 18.67 Million CAD | 731.53% |
| 2020 | 2.24 Million CAD | -63.53% |
| 2019 | 6.15 Million CAD | -56.98% |
| 2018 | 14.31 Million CAD | 187.97% |
| 2017 | 4.97 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.91 Million CAD | -26.97% |
| 2024 Q1 | 8.97 Million CAD | 37.53% |
| 2023 Q3 | 8.88 Million CAD | 16.14% |
| 2023 FY | 37.67 Million CAD | 62.38% |
| 2023 Q4 | 6.52 Million CAD | -26.54% |
| 2023 Q2 | 7.64 Million CAD | 59.4% |
| 2023 Q1 | 4.79 Million CAD | -45.48% |
| 2022 Q2 | 6.14 Million CAD | 81.11% |
| 2022 Q4 | 8.8 Million CAD | 80.81% |
| 2022 FY | 23.2 Million CAD | 24.23% |
| 2022 Q1 | 3.39 Million CAD | -1.45% |
| 2022 Q3 | 4.86 Million CAD | -20.75% |
| 2021 Q2 | 4.97 Million CAD | -4.18% |
| 2021 Q4 | 3.44 Million CAD | -32.02% |
| 2021 Q1 | 5.19 Million CAD | 12438.52% |
| 2021 FY | 18.67 Million CAD | 731.53% |
| 2021 Q3 | 5.06 Million CAD | 1.69% |
| 2020 Q2 | 676.23 Thousand CAD | -32.05% |
| 2020 FY | 2.24 Million CAD | -63.53% |
| 2020 Q4 | 41.43 Thousand CAD | -93.17% |
| 2020 Q3 | 606.45 Thousand CAD | -10.32% |
| 2020 Q1 | 995.22 Thousand CAD | 200.23% |
| 2019 Q3 | 1.57 Million CAD | 0.0% |
| 2019 FY | 6.15 Million CAD | -56.98% |
| 2019 Q4 | 331.48 Thousand CAD | -79.0% |
| 2018 FY | 14.31 Million CAD | 187.97% |
| 2017 FY | 4.97 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Appili Therapeutics Inc. | 8.83 Million CAD | -329.15% |
| Helix BioPharma Corp. | 9.35 Million CAD | -305.299% |
| Microbix Biosystems Inc. | 10.21 Million CAD | -271.155% |
| Medicenna Therapeutics Corp. | 19.66 Million CAD | -92.869% |
| Satellos Bioscience Inc. | 6.64 Million CAD | -470.626% |
| Oncolytics Biotech Inc. | 33.79 Million CAD | -12.23% |
| Sernova Corp. | 41.13 Million CAD | 7.797% |